Marshall Urist - 04 Nov 2026 Form 4 Insider Report for Royalty Pharma plc (RPRX)

Reporting relationship: EVP, Research & Investments
Issuer ticker: RPRX
Reported as of: 04 Nov 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Nov 2026, 16:17:38 UTC
Prior SEC filing: 05 Oct 2026
Source filing: View source filing
Reporting owner signature: /s/ Sean Weisberg, as Attorney-in-Fact, for Marshall Urist

Filing notes and source

Key filing fact

Marshall Urist filed Form 4 for Royalty Pharma plc (RPRX) on 06 Nov 2026.

Key facts

This page summarizes Marshall Urist's Form 4 filing for Royalty Pharma plc (RPRX).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 06 Nov 2026, 16:17.

Change

Previous filing in this sequence was filed on 05 Oct 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001838139 Primary reporting owner

Urist Marshall

Relationship: EVP, Research & Investments
Address: C/O ROYALTY PHARMA PLC, 110 EAST 59TH STREET, NEW YORK
Signature: /s/ Sean Weisberg, as Attorney-in-Fact, for Marshall Urist
Signature date: 06 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RPRX transaction

Class A Ordinary Shares

Award

Transaction value
Shares: +5,341
Change %
Price: $0.000000^*
Shares after: 5,341
Date: 04 Nov 2026
Ownership: Direct
Footnotes: F1

RPRX transaction

Class A Ordinary Shares

Conversion of derivative security

Transaction value
Shares: +150,000
Change %
Price: $0.000000^*
Shares after: 150,000
Date: 06 Nov 2026
Ownership: By Sandy Lamm LLC
Footnotes: F2

RPRX holding

Class A Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 19,020
Date: 04 Nov 2026
Ownership: By IRA

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RPRX transaction Derivative

LP interests in RPI US Partners 2019, LP

Conversion of derivative security

Transaction value
Shares: -15,000
Change %: -6.1%
Price: $0.000000^*
Shares after: 229,412
Date: 06 Nov 2026
Ownership: By Sandy Lamm LLC
Underlying class: Class A Ordinary Shares
Underlying amount: 150,000
Exercise price: $0.000000
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Reflects the exempt acquisition by the Reporting Person pursuant to Rule 16b-3 of Class A Ordinary Shares of the Issuer in connection with the settlement of Equity Performance Awards.

Footnote F2

These Class A Ordinary Shares will be received by the Reporting Person in exchange for limited partnership interests in RPI US Partners 2019, LP ("RPI US LP"). Each limited partnership interest in RPI US LP ("RPI US LP Interest") will be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited ("RPH"). Each Class B Interest in RPH so distributed will be exchanged for one Class A Ordinary Share of the Issuer. This exchange will be made pursuant to the terms of the Amended and Restated Exchange Agreement. No additional value will be paid by the Reporting Person in connection with the exchange.

Footnote F3

Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in RPH at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in RPH issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value.

SEC remarks

In addition to the Class A Ordinary Shares and RPI US LP Interests disclosed above, the Reporting Person holds Class E Ordinary Shares of RPH exchangeable into 1,356,528 Class A Ordinary Shares. Class E Ordinary Shares of RPH are subject to vesting conditions.